sameAs
Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic ArthritisNon-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary CholangitisComparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on DialysisStudy of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast CancerDose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast CancerInternational Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing SpondylitisAn International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque PsoriasisClinical Study of the Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers
P859
Q61907863-FF899057-A539-420B-9294-2F301C4B2411Q62813224-C47A8A0E-C78B-4985-A012-94A0AD68D8FFQ62816970-E1892520-BD05-40D2-ABB6-A155D0967984Q63229569-3E08C3F3-EFCD-481D-A5C0-2142FA0E855CQ63317395-CDE8EF3D-BAE1-4AF7-89B5-C4D49E086754Q63401436-0758DBE6-B740-418B-956A-CCB8954B8E64Q63405307-32F7626F-13BB-4CB0-BFCB-65C6FBDC2D8BQ63599322-F61ADFC3-4A62-429C-A53B-7A7B0FB49BF6
P859
description
bedrijf uit Rusland
@nl
company in Strel'na, Russia
@en
name
BIOCAD (Russia)
@en
Биокад
@ru
Биокад
@sr
type
label
BIOCAD (Russia)
@en
Биокад
@ru
Биокад
@sr
prefLabel
BIOCAD (Russia)
@en
Биокад
@ru
Биокад
@sr
P159
P1056
P17
P2427
grid.497515.b
P571
2001-01-01T00:00:00Z